Frontiers in Immunology (Apr 2020)

The CD83 Molecule – An Important Immune Checkpoint

  • Linda Grosche,
  • Ilka Knippertz,
  • Christina König,
  • Dmytro Royzman,
  • Andreas B. Wild,
  • Elisabeth Zinser,
  • Heinrich Sticht,
  • Yves A. Muller,
  • Alexander Steinkasserer,
  • Matthias Lechmann

DOI
https://doi.org/10.3389/fimmu.2020.00721
Journal volume & issue
Vol. 11

Abstract

Read online

The CD83 molecule has been identified to be expressed on numerous activated immune cells, including B and T lymphocytes, monocytes, dendritic cells, microglia, and neutrophils. Both isoforms of CD83, the membrane-bound as well as its soluble form are topic of intensive research investigations. Several studies revealed that CD83 is not a typical co-stimulatory molecule, but rather plays a critical role in controlling and resolving immune responses. Moreover, CD83 is an essential factor during the differentiation of T and B lymphocytes, and the development and maintenance of tolerance. The identification of its interaction partners as well as signaling pathways have been an enigma for the last decades. Here, we report the latest data on the expression, structure, and the signaling partners of CD83. In addition, we review the regulatory functions of CD83, including its striking modulatory potential to maintain the balance between tolerance versus inflammation during homeostasis or pathologies. These immunomodulatory properties of CD83 emphasize its exceptional therapeutic potential, which has been documented in specific preclinical disease models.

Keywords